Dosimetric Parameters After VMAT Adaptive Radiotherapy in Patients With Locally Advanced NSCLC Undergoing 4DCT

医学 放射治疗 核医学 轮廓 食管 放射治疗计划 肺癌 放射科 外科 内科学 工程类 工程制图
作者
Linda Agolli,Zeynep Eroglu,Luca Nicosia,Daniel Habermehl
出处
期刊:Anticancer Research [Anticancer Research USA Inc.]
卷期号:43 (12): 5573-5582
标识
DOI:10.21873/anticanres.16759
摘要

To investigate dosimetric differences in organs at risk (OARs) and cardiac substructures in patients with locally advanced non-small cell lung cancer (NSCLC) between the adaptive radiotherapy (ART) and non-ART groups.Thirty patients were treated with definitive radiotherapy +/- chemotherapy. Cardiac substructures including the left anterior descending coronary artery (LAD) and large vessels, were contoured. Eight patients experienced tumor shrinkage and were replanned (ART). Cumulative plans after ART were compared to the original plans (not considering volume reduction) in terms of dosimetric parameters. The cumulative plans of the ART group (n=8) and non-ART group (n=22) were compared in terms of the same dosimetric parameters.Within the ART group, the following parameters were found to be significantly improved after re-planning: mean lung dose (MLD) (13.79 Gy vs. 15.6 Gy), V20Gy both lungs (17.88% vs. 27.38%), ipsilateral MLD (20.87 Gy vs. 24.44 Gy), and esophagus mean dose (20.79 Gy vs. 24.2 Gy). No dosimetric differences were observed in heart substructures. Dosimetric parameters, particularly LAD, were significantly worse in the ART group than in the non-ART group. This is probably because this OAR was not considered in the plan optimization after re-planning, because it was not routinely contoured as an OAR.Our analysis showed an improvement in dosimetric parameters in the lungs and esophagus in the ART group. This approach may lead to a possible reduction in toxicity. Contouring of cardiac substructures could lead to a plan optimization of their parameters and eventually reduce the risk of cardiac toxicities in these patients.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
土豆王完成签到,获得积分10
刚刚
认真沅完成签到,获得积分10
刚刚
smileLn完成签到,获得积分20
刚刚
misalia完成签到,获得积分10
刚刚
害怕的路灯完成签到,获得积分10
1秒前
Bismarck发布了新的文献求助10
1秒前
为神武完成签到,获得积分10
1秒前
打打应助收手吧大哥采纳,获得30
1秒前
乐一李完成签到,获得积分10
1秒前
千江有水完成签到,获得积分10
1秒前
科研通AI6.2应助LULU采纳,获得10
1秒前
自由自在完成签到,获得积分10
1秒前
火星上映阳完成签到,获得积分10
1秒前
java完成签到,获得积分10
2秒前
小茗完成签到,获得积分10
2秒前
ZHI完成签到,获得积分10
2秒前
yuanyi_uni完成签到,获得积分10
3秒前
Marts完成签到,获得积分10
3秒前
完美世界应助俭朴乌采纳,获得10
3秒前
bkagyin应助科研通管家采纳,获得10
3秒前
Orange应助科研通管家采纳,获得10
3秒前
汉堡包应助科研通管家采纳,获得10
3秒前
冷酷丹琴完成签到,获得积分10
3秒前
nyfz2002完成签到,获得积分20
3秒前
千陽完成签到 ,获得积分10
3秒前
斯文败类应助金鑫采纳,获得10
4秒前
milk完成签到 ,获得积分10
4秒前
xzn1123完成签到,获得积分0
4秒前
梦璃完成签到 ,获得积分10
4秒前
uang完成签到,获得积分10
4秒前
qq完成签到,获得积分10
4秒前
Wonderland完成签到,获得积分10
5秒前
直率的钢铁侠完成签到,获得积分10
5秒前
晚睡是小狗应助卡瓦丽咔采纳,获得10
5秒前
qiandi完成签到,获得积分10
5秒前
笑点低的蜻蜓完成签到,获得积分10
5秒前
方块儿完成签到 ,获得积分10
5秒前
爆爆完成签到 ,获得积分10
5秒前
6秒前
王都对完成签到,获得积分10
6秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
Handbook of pharmaceutical excipients, Ninth edition 5000
Aerospace Standards Index - 2026 ASIN2026 2000
Digital Twins of Advanced Materials Processing 2000
晋绥日报合订本24册(影印本1986年)【1940年9月–1949年5月】 1000
Social Cognition: Understanding People and Events 1000
Polymorphism and polytypism in crystals 1000
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 纳米技术 有机化学 物理 生物化学 化学工程 计算机科学 复合材料 内科学 催化作用 光电子学 物理化学 电极 冶金 遗传学 细胞生物学
热门帖子
关注 科研通微信公众号,转发送积分 6034888
求助须知:如何正确求助?哪些是违规求助? 7748098
关于积分的说明 16207684
捐赠科研通 5181314
什么是DOI,文献DOI怎么找? 2773001
邀请新用户注册赠送积分活动 1756136
关于科研通互助平台的介绍 1641013